KR100396114B1 - Method for manufacturing d-cycloserine - Google Patents

Method for manufacturing d-cycloserine Download PDF

Info

Publication number
KR100396114B1
KR100396114B1 KR1019960050681A KR19960050681A KR100396114B1 KR 100396114 B1 KR100396114 B1 KR 100396114B1 KR 1019960050681 A KR1019960050681 A KR 1019960050681A KR 19960050681 A KR19960050681 A KR 19960050681A KR 100396114 B1 KR100396114 B1 KR 100396114B1
Authority
KR
South Korea
Prior art keywords
compound
reaction
formula
cycloserine
acid
Prior art date
Application number
KR1019960050681A
Other languages
Korean (ko)
Other versions
KR19980031145A (en
Inventor
장민선
옥광대
김문성
정동윤
조현욱
배중석
임태균
Original Assignee
동아제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 동아제약 주식회사 filed Critical 동아제약 주식회사
Priority to KR1019960050681A priority Critical patent/KR100396114B1/en
Publication of KR19980031145A publication Critical patent/KR19980031145A/en
Application granted granted Critical
Publication of KR100396114B1 publication Critical patent/KR100396114B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: Provided is a method for manufacturing D-cycloserine(D-4-amino-3-isoxazolidinone) of the formula(I) that is useful for the treatment of tuberculosis, massively. CONSTITUTION: A method for manufacturing D-cycloserine(D-4-amino-3-isoxazolidinone) of the formula(I) comprises the steps of; reacting a compound of the formula(II) with SOX2 and ROH to give a compound of the formula(IV); reacting the compound of the formula(IV) with hydroxylamine or its acid added salt to give an alkali salt compound of the formula(I); and neutralizing it with hydrobromic acid and hydroiodic acid.

Description

D-시클로세린의 제조방법Production method of D-cycloserine

본 발명은 D-시클로세린(D-4-아미노-3-이속사졸리디논)을 경제적이고 공업적으로 대량 생산할 수 있는 새롭고 진보된 방법에 관한 것이다.The present invention relates to a new and advanced method for economically and industrially mass-producing D-cycloserine (D-4-amino-3-isoxazolidinone).

D-시클로세린은 결핵치료에 사용되는 항생물질로서 다음의 구조식(Ⅰ)로 표시되는 화합물이다.D-Cycloserine is an antibiotic substance used in the treatment of tuberculosis and is a compound represented by the following structural formula (I).

D-시클로세린은 공지의 화합물이다.D-Cycloserine is a known compound.

이 화합물은 영국특허 제 1,223,887호에 그 제조방법이 기재되어 있으며, 이 방법에 의하면 D-α-아미노-β-클로로피로피온산 메틸에스테르 염산염을 출발물질로 하여 히드록실아민 염산염과 반응시켜서 D-α-아미노-β-클로로프로피오히드록사민산을 제조한 다음 가성소다 용액에서 고리화 반응하여 D-시클로세린을 제조한 후, D-시클로세린을 분리정제하기 위하여 다량의 8-히드록시퀴놀린을 사용하는 방법에 대하여 기술되어 있다. 그러나 이 방법은 고가인 8-히드록시퀴놀린을 다량 사용하여야 하기 때문에 양산 방법으로서는 적합하지 않다.This compound is described in British Patent No. 1,223,887. According to this method, D-α-amino-β-chloropyropionic acid methyl ester hydrochloride is used as a starting material and reacted with hydroxylamine hydrochloride to obtain D- α-amino-β-chloropropiohydroxamic acid was prepared and cyclized in a caustic soda solution to prepare D-cycloserine. To separate and purify D-cycloserine, a large amount of 8-hydroxyquinoline A method for using the above-mentioned method is described. However, this method is not suitable as a mass production method because a large amount of expensive 8-hydroxyquinoline must be used.

또한 미국특허 제 3,517,099호 및 영국특허 제 768,007호에서는 각각 스트렙토마이세스 올르키데시오스 균주를 이용한 발효법에 의거 D-사이클로세린을 제조하는 방법이 기술되어 있으며, 이 방법은 수득율이 낮아 경제성이 없는 것으로 알려져 있다.In addition, U.S. Patent No. 3,517,099 and British Patent No. 768,007 disclose a method for producing D-cycloserine by a fermentation method using a Streptomyces oryzdecios strain, respectively, and this method has a low yield and is not economical It is known.

본 발명자들은 이러한 문제점을 해결하기 위하여 오랜 연구를 행하여 본 발명을 완성하였다.The inventors of the present invention conducted a long study to solve this problem and completed the present invention.

본 발명의 목적은 출발물질로서 구조식 (Ⅱ)의 D-세린을 사용하여 여기에 ROH의 존재하에 SOX2를 반응시켜서 일반구조식 (Ⅲ)의 화합물을 제조한후 이 중간물질에 계속하여 SOX2를 반응시켜서 일반구조식(Ⅳ)의 화합물을 제조하고 이 중간화합물에 하이드록실아민 또는 그 산부가염을 반응시켜서 구조식 (Ⅰ)의 사이클로세린을 높은 수율과 순도로서 제조하는 방법을 제공하는 것이다. 이를 반응식으로 나타내면 다음과 같다.The object of the present invention is to provide a process for the preparation of a compound of general formula (III) by reacting SOX 2 with D-serine of the formula (II) as starting material in the presence of ROH, followed by addition of SOX 2 (IV), and reacting the intermediate compound with a hydroxylamine or an acid addition salt thereof to prepare a cycloserine of the formula (I) with high yield and purity. The reaction formula is as follows.

상기식에서 R은 탄소수 1-5의 저급알킬기이며, X는 할로겐원자를 나타낸다.In the above formula, R represents a lower alkyl group having 1-5 carbon atoms, and X represents a halogen atom.

탄소수 1-5의 저급알킬기란 메틸, 에틸, n-프로필, iso-프로필, n-부틸, iso-부틸, n-펜틸 등과 같은 알킬기를 나타내며, X는 염소 또는 브롬원자를 나타낸다.The lower alkyl group having 1-5 carbon atoms means an alkyl group such as methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or n-pentyl and X represents a chlorine or bromine atom.

(가) 일반식 (Ⅲ)의 화합물의 제조:(A) Preparation of the compound of the general formula (III): < EMI ID =

일반식 (Ⅱ)와 같은 아미노산 화합물을 비롯한 일반적인 카르본산 화합물을에스테르화 하기 위하여서는 일반적으로 염산가스를 포집한 알콜용매에서 환류반응시켜서 얻는다. 그러나 이 방법은 반응중에 생성된 물에 의해 생성된 에스테르 목적물이 가수분해 반응되어 다시 원래의 출발물질로 돌아가기 때문에 완벽하게 정량적인 수율로 목적물을 얻기가 힘들다.In order to esterify a general carboxylic acid compound including an amino acid compound such as the general formula (II), it is generally obtained by carrying out a reflux reaction in an alcohol solvent in which hydrochloric acid gas is captured. However, this method is difficult to obtain the target in a completely quantitative yield because the ester target produced by the water produced during the reaction is hydrolyzed and returned to the original starting material.

이와 같은 단점은 반응시약으로 브롬화 티오닐, 염화티오닐 등과 같은 할로겐화티오닐을 사용하여 염산, 아황가스로 배출시켜서 극복될 수 있다. 즉, 반응용매로 저급알콜, 예를들면, 메틸알콜, 에틸알콜, n-프로필알콜 등과 같은 저급알콜이 적합하며, 이중에서도 메틸알콜를 사용하는 것이 바람직하다.These disadvantages can be overcome by using thionyl halides such as thionyl bromide, thionyl chloride and the like as reaction reagents and discharging them with hydrochloric acid and sulfur gas. That is, lower alcohol such as methyl alcohol, ethyl alcohol, n-propyl alcohol and the like is suitable as a reaction solvent, and it is preferable to use methyl alcohol.

반응물질로서는 브롬화티오닐, 염화티오닐이 바람직하다.As the reaction substance, thionyl bromide and thionyl chloride are preferable.

반응은 D-세린 1몰에 대하여 할로겐화티오닐 1 - 3몰 사용한다.The reaction is carried out using 1 to 3 moles of thionyl halide per mole of D-serine.

반응온도는 20℃ 내지 사용된는 용매의 비점온도, 바람직하게는 20 - 40℃사이의 온도에서 행하는 것이 유리하다.It is advantageous to carry out the reaction at a temperature of from 20 캜 to the boiling point of the solvent used, preferably between 20 and 40 캜.

반응은 통상 3 - 12시간에서 정량적으로 완결된다. 반응종료후 통상적 방법에 따라 처리되고, 일반식 (Ⅲ)의 화합물은 거의 정량적으로 얻어진다.The reaction is usually completed quantitatively at 3 - 12 hours. After completion of the reaction, the compound is treated according to a conventional method, and the compound of the formula (III) is obtained almost quantitatively.

(나) 일반식 (Ⅳ)의 제조:(B) Preparation of general formula (IV)

일반식 (Ⅳ)의 화합물은 일반식 (Ⅲ)의 화합물을 할로겐화 시약인 오염화인을 사용하여 클로로포름 용매중에서 반응시켜서 제조하는 것이 기지의 방법이나, 사용하는 오염화인은 그 자체로서 매우 유독할 뿐만아니라 승화성 고체시약으로서 취급하기가 매우 곤란하고 위험한 물질로서 대량생산 공정에 적용하는 것은 부적합하다. 따라서, 본 발명자들은 이와같은 단점을 할로겐하제 액체시약인 브롬화티오닐과 염화티오닐을 사용하여 극복될 수 있었다. 즉 반응용매로는 디클로로메탄, 클로로포름, 에틸아세테이트, 테트라하이드로퓨란, 디옥산, 톨루엔등이 적합하다. 반응은 화합물(Ⅲ)에 대하여 염화티오닐 1 - 3몰을 사용한다. 반응온도는 20℃- 사용된 용매의 비점온도에서 행하며, 30 - 60℃에서 행하는 것이 바람직하다. 반응은 통상으로 4 - 15시간에서 정량적으로 완결되어 일반식 (Ⅳ)의 화합물이 97%이상의 수율로 얻어진다.The compound of the general formula (IV) is a known method in which a compound of the general formula (III) is reacted in a chloroform solvent using a phosphorylating reagent as a halogenating reagent, but the phosphorylating agent used is very toxic as such It is very difficult to treat as a sublimation solid reagent and it is not suitable to apply to a mass production process as a dangerous substance. Thus, the inventors could overcome this disadvantage by using thionyl bromide and thionyl chloride as halogenating reagents. As the reaction solvent, dichloromethane, chloroform, ethyl acetate, tetrahydrofuran, dioxane, toluene and the like are suitable. The reaction uses 1 to 3 moles of thionyl chloride relative to the compound (III). The reaction temperature is 20 ° C - the boiling point of the solvent used, and preferably 30 to 60 ° C. The reaction is usually completed quantitatively at 4 - 15 hours and the compound of formula (IV) is obtained in a yield of 97% or more.

일반식 (Ⅲ)의 화합물과 일반식 (IV)의 제조는 한 반응기내에서 (나)애서 사용되는 유기용매중에서 당량의 ROH존재하에 할로겐화티오닐과 반응시켜서 구조식(Ⅱ)의 화합물로부터 직접 제조될 수도 있다.The preparation of the compounds of the general formula (III) and the general formula (IV) can be carried out in the presence of an equivalent amount of ROH in an organic solvent used in a reactor (b) to give thionyl halide to be prepared directly from the compound of the structural formula (II) It is possible.

(다) 화합물 (Ⅰ)의 제조:(C) Preparation of compound (I)

구조식 (Ⅰ)의 화합물은 일반식 (IV)의 화합물을 염산 히드록실아민과 반응시켜서 D-α-아미노-β-클로로 프로피오히드록사민산으로 전환시킨후, 계속하여 동일 반응기내에서 고리화 반응까지 진행되어 얻어지게 된다. 그러나, 이 화합물은 물에 대한 용해도가 높은 반면 유기용매에 대한 용해도가 극히 낮을 뿐만 아니라 염기성 수용액에서는 비교적 안정하나, 산성 수용액중에서는 불안정하기 때문에 반응액에서부터 이 물질을 순수한 형태로 얻는 것은 매우 어려운 문제로 되어 있다.The compound of formula (I) can be prepared by reacting a compound of formula (IV) with hydroxylamine hydrochloride to convert it to D- [alpha] -amino- [beta] -chloropropiohydroxamic acid and subsequently cyclizing And the reaction proceeds until it reaches the reaction. However, since this compound has a high solubility in water, it is extremely low in solubility in an organic solvent and relatively stable in a basic aqueous solution, but is unstable in an acidic aqueous solution. Therefore, it is very difficult to obtain this substance in pure form from a reaction solution .

반응액에서부터 화합물 (Ⅰ)을 분리하기 위한 방법으로는 공지 방법으로는 두방법이 있다.As a known method for separating the compound (I) from the reaction solution, there are two methods.

첫째는 이온교환수지를 이용하여 화합물(Ⅰ)을 분리하는 방법으로 이 방법은 이 화합물은 화합물(Ⅰ)의 불안정성과 낮은 수율 등으로 경제성이 낮아 산업화에부적절하다.First, a method of separating compound (I) using an ion exchange resin, which is unsuitable for industrialization due to low economical efficiency due to instability of compound (I) and low yield.

두번째는 반응이 완결된 알칼리 반응용액에 저급알콜 용매를 가하여 생성된 무기염을 여과 제거한 다음, 빙초산으로 pH6.0으로 맞추어 생성되는 화합물(Ⅰ)을 여과 분리하는 방법이다. 그러나 이 방법은 수율이 낮을 뿐만아니라 최종화합물(Ⅰ)에 다량의 초산이 잔류용매로 남아 있기 때문에 고순도의 D-시클로세린을 얻기가 힘들다. 따라서 본 발명자들은 pH 5.5 - 6.5로 낮추는 여러가지 다른 방법을 연구한 결과 브롬화수소산, 요오드화수소산, 등의 무기산으로 pH를 조절하는 것이 가장 적절한 방법임을 알아냈다. 즉, 염산으로 pH를 조절할 경우에는 생성된 염화나트륨이 알콜용매중에서 D-시클로세린보다 용해도가 훨씬 낮기 때문에 생성된 D-시클로세린중에는 다량의 염화나트륨이 함유되어 있어 순도가 좋지 못하였다. 그러나 중화제로 브롬화수소산 또는 요오드화 수소산을 사용할 경우 생성되는 무기염인 브롬화 나트륨, 요오드화 나트륨 등은 D-시클로세린보다 훨씬 용해도가 좋아 알콜용매에 전부 용해하여 제거되기 때문에 고체상태의 고순도 D-시클로세린을 높은 수율로 얻을 수가 있었다.Secondly, a lower alcohol solvent is added to the alkali reaction solution in which the reaction is completed, and the resulting inorganic salt is removed by filtration, followed by adjusting to pH 6.0 with glacial acetic acid to separate the resulting compound (I) by filtration. However, this method is not only low in yield but also difficult to obtain a high purity D-cyclocerein because a large amount of acetic acid remains as a residual solvent in the final compound (I). Thus, the present inventors have studied various other methods of lowering the pH to 5.5 - 6.5 and found that adjusting the pH to inorganic acids such as hydrobromic acid, hydroiodic acid, etc. is the most suitable method. That is, when the pH was adjusted with hydrochloric acid, the produced sodium chloride was much lower in solubility than D-cycloserine in the alcohol solvent, so that the produced D-cycloserine contained a large amount of sodium chloride and thus had poor purity. However, when sodium hydrobromide or hydroiodic acid is used as a neutralizing agent, the inorganic salts such as sodium bromide and sodium iodide are much more soluble than D-cycloserine, so they are completely dissolved in the alcohol solvent and removed. Therefore, solid state high purity D- The yield was high.

이 방법으로 얻은 결과를 정리하여 보면 다음과 같다.The results obtained by this method are summarized as follows.

* 소디움 니트로페리시아나이드와 반응시킨후 파장 645nm에서 투과도 측정* After reacting with sodium nitroperi- canide, measurement of transmittance at 645 nm wavelength

이 반응의 반응용매로서는 물, 저급알콜, 예를들면 메틸알콜, 에틸알콜, n-프로필알콜, iso-프로필알콜 등 또는 물과 이들의 저급알콜의 혼합용매를 사용하는 것이 바람직하다.As the reaction solvent for this reaction, it is preferable to use water, a lower alcohol such as methyl alcohol, ethyl alcohol, n-propyl alcohol, iso-propyl alcohol or a mixed solvent of water and a lower alcohol.

고리화를 시키기 위해 일반식(Ⅳ)의 화합물 1몰에 대해 고리화를 시키기 위한 시약인 히드록실아님을 1.0 - 4.0몰, 바람직하게는 1.0 - 2.0몰을 사용한다. 반응온도는 -10 - 40℃, 바람직하게는 0 - 20℃에서 생해지며, 반응시간은 2 - 18 시간, 통상의 반응pH는 10.0 - 11.0으로 유지하는 것이 적당하다.1.0 to 4.0 mol, preferably 1.0 to 2.0 mol, of hydroxylamine, which is a reagent for cyclizing to 1 mol of the compound of the general formula (IV), is used for cyclization. The reaction temperature is -10 to 40 ° C, preferably 0 to 20 ° C. The reaction time is preferably 2 to 18 hours, and the usual reaction pH is preferably 10.0 to 11.0.

고순도 D-시클로세린을 고체로 석출하기 위해서 pH5.5 - 6.5로 조절하기 위한 시약으로서 브롬화 수소산, 요오드화 수소산 등이 절대 필요하다.In order to precipitate high-purity D-cycloserine as a solid, hydrobromic acid, hydroiodic acid, and the like are absolutely necessary as reagents for adjusting the pH to 5.5 to 6.5.

다음에 본 발명을 더욱 상세히 설명하기 위한 실시예를 예시하나, 이들 실시예가 본 발명의 범위를 제한하는 것은 아니다.EXAMPLES The following examples illustrate the present invention in further detail, but are not intended to limit the scope of the present invention.

실시예 1Example 1

D-세린메틸에스테르 염산염의 제조:Preparation of D-serine methyl ester hydrochloride:

3리터반응부에 D-세린(102.9g, 0.979mole)과 메탄올(1리터)를 넣고 -10℃로냉각시킨 다음 염화티오닐(147.7g, 1.468mole)을 천천히 적가한후 반응부의 온도를 올려 30℃에서 8시간동안 교반한다. 반응부를 냉각시킨 다음 메탄올과 염화티오닐을 감압농축하여 D-세린메틸에스테르 염산염(152.3g, 정략적)을 얻는다.D-serine (102.9 g, 0.979 mole) and methanol (1 liter) were added to the 3-liter reaction part and cooled to -10 ° C. Thionyl chloride (147.7 g, 1.468 mole) was slowly added dropwise and the temperature of the reaction part was raised The mixture is stirred at 30 DEG C for 8 hours. After cooling the reaction part, methanol and thionyl chloride were concentrated under reduced pressure to obtain D-serine methyl ester hydrochloride (152.3 g, in general).

실시예 2Example 2

D-α-아미노-β-클로로프로피온산 메틸에스테르염산염의 제조:Preparation of D-α-amino-β-chloropropionic acid methyl ester hydrochloride:

D-세린 메틸에스테르 염산염(152.3g, 0.979mole)이 들어 있는 3리터반응부에 1,4-디옥산(1.0리터)를 넣고 0℃로 냉각시킨 다음 염화티오닐(151.4g, 1.273mole)을 천천히 넣는다. 이 반응용액을 50℃의 온도로 올린 후 5시간 교반한다음 감압농축한다. 반응부에 아센톤(1.0리터)을 넣은 다음 30분간 교반시킨 후 여과 건조하여 고체인 D-α-아미노-β-클로로프로피온산 메틸에스테르 염산염(166.6g, 97.8%)을얻는다.1,4-dioxane (1.0 liter) was added to a 3-liter reaction portion containing D-serine methyl ester hydrochloride (152.3 g, 0.979 mole), and the mixture was cooled to 0 ° C. Thionyl chloride (151.4 g, 1.273 mole) Slowly. The reaction solution is heated to a temperature of 50 ° C, stirred for 5 hours, and then concentrated under reduced pressure. (1.0 liter) was added to the reaction part and stirred for 30 minutes, followed by filtration and drying to obtain solid D-α-amino-β-chloropropionic acid methyl ester hydrochloride (166.6 g, 97.8%).

실시예 3Example 3

D-시클로세린의 제조(1):Preparation of D-Cycloserine (1):

염산 히드록실아민(70.25g, 1.011mole)수용액(103ml)에 가성소다(124.7g, 3.113mole)수용액(150ml)을 10℃이하로 유지되도록 냉각하면서 천천히 적가한후 10분간 교반시킨다음 이 반응액 D-α-아미노-β-클로로피로피온산 메틸에스테르 염산염(146.65g, 0.843mole)의 수용액(242ml)을 반응액의 온도가 5℃이하로 유지되도록 하면서 빠르게 적가한다. 반응액의 pH가 10 - 11의 범위가 되도록 50% 가성소다 용액을 보충하면서 실온에서 4.5시간 반응시킨다. 반응이 끝난후 반응혼합물에 에탄올(6.6리터)를 넣고 20분간 교반시킨다음 생성된 고체를 여과 제거한다.(124.7 g, 3.113 mole) aqueous solution (150 ml) was slowly added dropwise while cooling the solution to 10 ° C or lower, and then stirred for 10 minutes. To this reaction solution An aqueous solution (242 ml) of D-? - amino -? - chloropyropionic acid methyl ester hydrochloride (146.65 g, 0.843 mole) is added dropwise while maintaining the temperature of the reaction solution at 5 ° C or lower. React at room temperature for 4.5 hours while supplementing the 50% caustic soda solution so that the pH of the reaction solution is in the range of 10 - 11. After the reaction was completed, ethanol (6.6 liters) was added to the reaction mixture, stirred for 20 minutes, and the resulting solid was filtered off.

여액을 0℃로 냉각시킨후 48% 브롬화수소산 용액을 서서히 가하여 pH6.0 -6.5로 조절하여 생성된 고체를 여과한 후 건조하여 D-시클로세린(73.3g, 85.2%)를얻는다.The filtrate was cooled to 0 ° C and 48% hydrobromic acid solution was slowly added thereto to adjust the pH to 6.0-6.5. The resulting solid was filtered and dried to obtain D-cyclocerein (73.3 g, 85.2%).

실시예 4Example 4

D-시클로세린의 제조(Ⅱ):Preparation of D-Cycloserine (II):

염산히드록실아민(70.25g, 1.011mole) 수용액(103ml)에 가성소다(124.7g, 3.113mole)수용액(150ml)를 10℃이하로 유지되도록 냉각하면서 천천히 적가한 후 10분간 교반시킨다음 이 반응액에 D-α-아미노-β-클로로피로피온산 메틸에스테르염산염(146.65g, 0.843mole)의 수용액(242ml)을 반응액의 온도가 5℃이하로 유지되도록 하면서 빠르게 적가한다. 반응액의 pH가 10 -11의 범위가 되도록 50% 가성소다 용액을 보충하면서 실온에서 4.5시간 반응시킨다. 반응이 끝난후 반응혼합물에 에탄올(6.6리터)를 넣고 20분간 교반시킨 다음 생성된 고체를 여과 제거한다.(124.7 g, 3.113 mole) aqueous solution (150 ml) was slowly added dropwise to the aqueous solution (103.25 ml) of hydroxylamine hydrochloride (70.25 g, 1.011 mole) while maintaining the temperature at 10 ° C or lower, stirred for 10 minutes, An aqueous solution (242 ml) of D-? - amino-? - chloropyropionic acid methyl ester hydrochloride (146.65 g, 0.843 mole) is added dropwise while maintaining the temperature of the reaction solution at 5 ° C or lower. The reaction was carried out at room temperature for 4.5 hours while supplementing the 50% caustic soda solution so that the pH of the reaction solution was in the range of 10 -11. After the reaction was completed, ethanol (6.6 liters) was added to the reaction mixture, stirred for 20 minutes, and the resulting solid was filtered off.

여액을 0℃로 냉각시민후 47% 요오드화수소산 용액을 서서히 가하여 pH 6.0 - 6.5로 맞추어 생성된 고체를 여과한후 건조하여 D-시클로세린(71.5g, 83.1%)을얻는다.The filtrate is cooled to 0 ° C, and 47% hydroiodic acid solution is slowly added to adjust pH to 6.0-6.5. The resulting solid is filtered and dried to obtain D-cyclocerein (71.5g, 83.1%).

Claims (1)

구조식 (Ⅱ)의 화합물을 SOX2및 ROH와 반응시켜서 얻어진 일반구조식(Ⅳ)의 화합물을 알칼리성에서 히드록실아민 또는 그 산부가염과 반응시켜서 구조식 (Ⅰ)의 알카리염 화합물을 생성시킨 다음 브롬화수소산 및 요오드화수소산에서 선택된 산으로 중화시켜서 구조식 (Ⅰ)의 D-시클로세린을 제조하는 방법.A compound of general formula (IV) obtained by reacting a compound of formula (II) with SOX 2 and ROH is reacted with hydroxylamine or its acid addition salt in an alkaline to produce an alkaline salt compound of formula (I) (I) with an acid selected from hydroiodic acid, to produce D-cycloserine of structural formula (I). 상기식에서 R은 탄소수 1-5인 저급알킬기이며, X는 염소 또늠 브롬원자이다.Wherein R is a lower alkyl group having 1-5 carbon atoms and X is a chlorine atom. 탄소수 1-5의 저급알킬기란 메틸, 에틸, n-프로필, iso-프로필, n-부필, iso-부틸, n-펜틸 등과 같은 알킬기를 나타내며, X는 염소 또는 브롬원자를 나타낸다.The lower alkyl group having 1-5 carbon atoms means an alkyl group such as methyl, ethyl, n-propyl, isopropyl, n-biphenyl, isobutyl, n-pentyl and the like and X represents a chlorine or bromine atom.
KR1019960050681A 1996-10-31 1996-10-31 Method for manufacturing d-cycloserine KR100396114B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960050681A KR100396114B1 (en) 1996-10-31 1996-10-31 Method for manufacturing d-cycloserine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960050681A KR100396114B1 (en) 1996-10-31 1996-10-31 Method for manufacturing d-cycloserine

Publications (2)

Publication Number Publication Date
KR19980031145A KR19980031145A (en) 1998-07-25
KR100396114B1 true KR100396114B1 (en) 2003-11-20

Family

ID=37422114

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960050681A KR100396114B1 (en) 1996-10-31 1996-10-31 Method for manufacturing d-cycloserine

Country Status (1)

Country Link
KR (1) KR100396114B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101841355B1 (en) * 2016-09-02 2018-03-22 영남대학교 산학협력단 Pharmaceutical formulations of D-cycloserine and process for manufacturing the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517099A (en) * 1968-06-10 1970-06-23 Commercial Solvents Corp Production of a cycloserine-o-carbamyl-d-serine composition
KR850000209A (en) * 1983-06-02 1985-02-26 로이 이. 모르스 Filter rod manufacturing apparatus and method
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
JPH07330744A (en) * 1994-06-01 1995-12-19 Sankyo Kasei Kogyo Kk 5-alkoxy-3-isoxazolidinone, its production and use thereof
KR19990074617A (en) * 1998-03-12 1999-10-05 유충식 Method for preparing di-cycloserine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517099A (en) * 1968-06-10 1970-06-23 Commercial Solvents Corp Production of a cycloserine-o-carbamyl-d-serine composition
KR850000209A (en) * 1983-06-02 1985-02-26 로이 이. 모르스 Filter rod manufacturing apparatus and method
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
JPH07330744A (en) * 1994-06-01 1995-12-19 Sankyo Kasei Kogyo Kk 5-alkoxy-3-isoxazolidinone, its production and use thereof
KR19990074617A (en) * 1998-03-12 1999-10-05 유충식 Method for preparing di-cycloserine

Also Published As

Publication number Publication date
KR19980031145A (en) 1998-07-25

Similar Documents

Publication Publication Date Title
EP0595345B1 (en) Process for producing alanylglutamine
CN114805314A (en) Synthesis method of Ensaitevir
CN111533710B (en) Method for preparing cefotiam intermediate 2-aminothiazole-4-acetic acid by one-pot method
KR100396114B1 (en) Method for manufacturing d-cycloserine
SU882409A3 (en) Method of preparing halogen-substituted mercaptoacylamino acids
US6476220B2 (en) Process for the preparation of furaca
KR910003709B1 (en) Process for the preparation of butyl 3'-(1h-tetrazole-5-yl)oxanylrate
KR20030050412A (en) A process for preparing rebamipide
KR0163042B1 (en) Process for the preparation of 4-amino-5-hexenic acids
US20230027871A1 (en) Method for preparing lifitegrast
KR20020052213A (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
KR100522246B1 (en) Method for preparing di-cycloserine
KR950001026B1 (en) Process for preparing penicillanic acid derivatives
KR100351743B1 (en) Process for preparation of the n,n-dicyclohexyl-2-benzothiazole sulfenamide
KR100293728B1 (en) Process for producing crystalline cefpirom sulfate
JP5087059B2 (en) Process for producing 4- (2-methyl-1-imidazolyl) -2,2-diphenylbutanamide
US4758679A (en) Preparation of 7-(3-(propylamino)-2-hydroxypropoxy)flavone
JP3257779B2 (en) Method for producing tartanyl acids
KR960005518B1 (en) Process for the preparation of 1-amino-4-££2-(substituted amino)methyl-4-methyl-6-sylfophenyl|amino|-9,10-dihydro-9,10-dioxo-2-anthrqcene sulfonic acid|amino|-9,10-dihydro-9,10-dioxo-2-anthracent sulfonic acid
JPH11292869A (en) Production of ipriflavone
IE58082B1 (en) A process for the preparation of compounds containing carboxamide groups, in particular of peptides
US4375543A (en) N-[3-(1'-3"-Oxapentamethylene-amino-ethylideneamino)-2,4,6-triiodobenzoyl]-β-amino-α- methylpropionitrile in process to make corresponding acid
KR870000724B1 (en) Process for preparing cephalosphorin derivatives
JPH04270272A (en) Production of aminoalkylmorpholine derivative
KR900001080B1 (en) A preparation process for pyrazolone derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20131226

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20141211

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20151230

Year of fee payment: 14